Search research articles
Contact Us
Filters
Showing results (961-970 of 1,025) with videos related to
Page
of 103
Sort By:
JAMA Network Open
|
February 8, 2021
Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia
Elizabeth T Rogawski McQuade, Kristin A Guertin, Lea Becker, et al.
Prostate Cancer and Prostatic Diseases
|
July 17, 2024
Body composition as a determinant of the therapeutic index with androgen signaling inhibition
Andrew W Hahn, Rebecca S Tidwell, Patrick G Pilie, et al.
Annals of Surgical Oncology
|
March 16, 2026
Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection
Joshua Herb, Roland L Bassett, Carlos A Torres-Cabala, et al.
ACS Medicinal Chemistry Letters
|
July 19, 2023
Discovery of [<sup>11</sup>C]MK-8056: A Selective PET Imaging Agent for the Study of mGluR<sub>2</sub> Negative Allosteric Modulators
James J Perkins, Paul McQuade, Christopher J Bungard, et al.
Journal of Parkinson'S Disease
|
April 17, 2026
Autoradiography and preclinical PET studies with radiolabeled asyn-44 and ACI-12589 for imaging α-synuclein
Cassis Varlow, Anna Pees, Jeffrey S Stehouwer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma
Y N Vashisht Gopal, Seth Gammon, Rishika Prasad, et al.
Journal for Immunotherapy of Cancer
|
May 22, 2021
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma
Chantal Saberian, Rodabe N Amaria, Amer M Najjar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2016
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
A M Menzies, D B Johnson, S Ramanujam, et al.
Cancer Discovery
|
March 3, 2018
A Preexisting Rare <i>PIK3CA</i><sup>E545K</sup> Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in <i>NRAS</i> Melanoma and Is Dependent on S6K1 Signaling
Gabriele Romano, Pei-Ling Chen, Ping Song, et al.
Nutrients
|
January 10, 2026
Investigating Chronic Toxicity, Diet, Patient-Reported Outcomes and the Microbiome in Immunotherapy-Treated Metastatic Melanoma Survivors: A New Frontier
Margaux Robert, Satabdi Saha, Nazli Dizman, et al.
Page
of 103
Search research articles
Search
Showing results (961-970 of 1,025) with videos related to
Sort By:
Page
of 103
JAMA Network Open
|
February 8, 2021
Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia
Elizabeth T Rogawski McQuade, Kristin A Guertin, Lea Becker, et al.
Prostate Cancer and Prostatic Diseases
|
July 17, 2024
Body composition as a determinant of the therapeutic index with androgen signaling inhibition
Andrew W Hahn, Rebecca S Tidwell, Patrick G Pilie, et al.
Annals of Surgical Oncology
|
March 16, 2026
Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection
Joshua Herb, Roland L Bassett, Carlos A Torres-Cabala, et al.
ACS Medicinal Chemistry Letters
|
July 19, 2023
Discovery of [<sup>11</sup>C]MK-8056: A Selective PET Imaging Agent for the Study of mGluR<sub>2</sub> Negative Allosteric Modulators
James J Perkins, Paul McQuade, Christopher J Bungard, et al.
Journal of Parkinson'S Disease
|
April 17, 2026
Autoradiography and preclinical PET studies with radiolabeled asyn-44 and ACI-12589 for imaging α-synuclein
Cassis Varlow, Anna Pees, Jeffrey S Stehouwer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma
Y N Vashisht Gopal, Seth Gammon, Rishika Prasad, et al.
Journal for Immunotherapy of Cancer
|
May 22, 2021
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma
Chantal Saberian, Rodabe N Amaria, Amer M Najjar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2016
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
A M Menzies, D B Johnson, S Ramanujam, et al.
Cancer Discovery
|
March 3, 2018
A Preexisting Rare <i>PIK3CA</i><sup>E545K</sup> Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in <i>NRAS</i> Melanoma and Is Dependent on S6K1 Signaling
Gabriele Romano, Pei-Ling Chen, Ping Song, et al.
Nutrients
|
January 10, 2026
Investigating Chronic Toxicity, Diet, Patient-Reported Outcomes and the Microbiome in Immunotherapy-Treated Metastatic Melanoma Survivors: A New Frontier
Margaux Robert, Satabdi Saha, Nazli Dizman, et al.
Page
of 103